R1 RCM 2021 J.P. Morgan Healthcare Conference Presentation

R1 presents its technology-driven revenue cycle management platform at the 39th Annual J.P. Morgan Healthcare Conference. The company highlights its market leadership in acute and physician RCM with >90% recurring revenue, projecting 2021 Adjusted EBITDA of $315-330M from $230-240M in 2020.